AMY HIRBY: Open Payments
NPI 1710313523 · BARDSTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,665 in 194 payments from 19 companies in 2025. Trend: 2023 $824 · 2024 $2,353 · 2025 $3,665
Food & beverage: $3,416Education: $249
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 18 | $433 |
| Regeneron Healthcare Solutions, Inc. | 16 | $376 |
| Janssen Biotech, Inc. | 19 | $368 |
| ABBVIE INC. | 29 | $353 |
| Galderma Laboratories, L.P. | 19 | $324 |
| Amgen Inc. | 13 | $310 |
| UCB, Inc. | 14 | $303 |
| Novartis Pharmaceuticals Corporation | 11 | $224 |
| E.R. Squibb & Sons, L.L.C. | 8 | $219 |
| Arcutis Biotherapeutics, Inc. | 17 | $183 |
Products named: DUPIXENT, TREMFYA, OTEZLA, Bimzelx, NEMLUVIO, Sotyktu, SKYRIZI, Zoryve.
Industry payments across KY — which companies pay providers there.
